The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 14, 1999, Pages 1985-1990

  Lindell, Stephen D ^a,b   Moloney, Brian A ^a   Hewitt, Brian D ^a   Earnshaw, Christopher G ^a   Dudfield, Philip J ^a   Dancer, Jane E ^a  

^a AgrEvo UK Limited   (United Kingdom)

^b SANOFI   (France)

Author keywords

Enzyme inhibitors; Herbicides; Nucleosides; Nucleotides

Indexed keywords

ADENOSINE 5' MONOPHOSPHATE DEAMINASE; ADENOSINE KINASE INHIBITOR; HERBICIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; ENZYME INHIBITION; SYNTHESIS; UNITED KINGDOM;

ADENOSINE; ADENOSINE TRIPHOSPHATE; AMP DEAMINASE; COFORMYCIN; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FORMYCINS; HERBICIDES; INHIBITORY CONCENTRATION 50; PHOSPHORYLATION; PURINE NUCLEOSIDES; RIBONUCLEOSIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033584175     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00298-X     Document Type: Article

References (27)

1. Merkler, D.J.; Kline, P.C.; Weiss, P.; Schramm, V.L. Biochemistry, 1993, 32, 12993.
2. Merkler, D.J.; Schramm, V.L. ibid., 5792.
3. Chapman, A.G.; Atkinson, D.E. J. Biol. Chem., 1973, 248, 8309.
4. Pradet, A.; Raymond, P. Ann. Rev. Plant Physiol., 1983, 34, 199.
5. Dancer, J.E.; Hughes, R.G.; Lindell, S.D. Plant Physiol., 1997, 114, 119.
6. This work represents part of an ongoing interest within AgrEvo in using mechanism-based biochemical reasoning to generate leads for the disccovery of new agrochemicals. For other recent examples see Dancer, J.E.; Ford, M.J.; Hamilton, K.; Kilkelly, M.; Lindell S.D.; O'Mahony, M.J.; Saville-Stones, E.A. Bioorg. Med. Chem. Lett., 1996, 6, 2131.
7. Lindell, S.D.; Earnshaw, C.G.; Wright, B.J.; Carver, D.S.; O'Mahony, M.J.; Saville-Stones, E.A. ibid., 547 and references cited therein.
8. Bush, B.D.; Fitchett, G.V.; Gates, D.A.; Langley, D. Phytochemistry, 1993, 32, 737.
9. Saville-Stones, E.A.; Turner, R.M.; Lindell, S.D.; Jennings, N.S.; Head, J.C.; Carver, D.S. Tetrahedron, 1994, 50, 6695.
10. Frieden, C.; Kurz, L.C.; Gilbert, H.R. Biochemistry, 1980, 19, 5303.
11. 3,7
12. 3,7
13. Bennett, L.L,; Allan, P.W.; Rose, L.M.; Comber, R.N.; Secrist, J.A. Molecular Pharmacology, 1986, 29, 383.
14. Dye, F.J.; Rossomando, E.F. Bioscience Reports, 1982, 2, 229. Bzowska, A.; Shugar, D. Z. Naturforschung, 1989, 44c, 581.
15. Dye, F.J.; Rossomando, E.F. Bioscience Reports, 1982, 2, 229. Bzowska, A.; Shugar, D. Z. Naturforschung, 1989, 44c, 581.
16. We wish to thank Glaxo Group Research, Greenford for supplying us with a sample of aristeromycin. Formycins A and B were purchased from the Sigma Chemical Company.
17. Nair, V.; Chamberlain, S.D. Synthesis, 1984, 401.
18. Long, R.A.; Lewis, A.F.; Robins, R. K.; Townsend, L. B. J. Chem. Soc.(C), 1971, 2443. Milne, G.H.; Townsend, L.B. J. Chem. Soc. Perkin Trans. 1, 1972, 2677.
19. Long, R.A.; Lewis, A.F.; Robins, R. K.; Townsend, L. B. J. Chem. Soc.(C), 1971, 2443. Milne, G.H.; Townsend, L.B. J. Chem. Soc. Perkin Trans. 1, 1972, 2677.
20. m 35 μM, [adenosine]= 60 μM).
21. Dale, G.L.; Norenberg, S.L. Blood, 1989, 74, 2157.
22. Paglia, D.E.; Valentine, W.N.; Nakatani, M.; Brockway, R.A. ibid., 2161.
23. Orozco, M.; Canela, E.I.; Franco, R. Molecular Pharmacology, 1989, 35, 257.
24. MOPAC 6.0 (QCPE 455): Stewart, J.J.P. J. Comp.-aided Mol. Des., 1990, 4, 1.
25. -1 more favourable than hydration of nebularine 5′-monophosphate (5).
26. A similar explanation has been proposed to account for the enhanced binding of 8-azapurine riboside (compared with nebularine) to the enzyme adenosine deaminase: Erion, M.D.; Reddy, M.R. J. Am. Chem. Soc., 1998, 120, 3295.
27. Shewach, D.S.; Krawczyk, S.H.; Acevedo, O.L.; Townsend, L.B. Biochem. Pharmacol., 1992, 44, 1697.